Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alexandre Sierra"'
Autor:
Irene Casanova-Salas, Sarai Cordoba-Terreros, Daniel Aguilar, Laura Agundez, Julian Brandariz, Nicolas Herranz, Macarena Gonzalez, Rafael Morales-Barrera, Alexandre Sierra, Mario Soriano-Navarro, Pablo Cresta, Sara Simonetti, Gonçalo Rodrigues, Sara Arce-Gallego, Luisa Delgado-Soriano, Irene Agustí, Elena Castellano-Sanz, Richard Mast, Matias de Albert, Ana Celma, Anna Santamaria, Lucila Gonzalez, Natalia Castro, Maria del Mar Suanes, Javier Hernández-Losa, Lara Nonell, Hector Peinado, Joan Carles, Joaquin Mateo
Extracellular vesicles (EVs) secreted by tumors are abundant in plasma, but their potential for interrogating the molecular features of tumors through multi-omic profiling remains widely unexplored. Genomic and transcriptomic profiling of circulating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca2255bac9a0e4dedc68abf76d7859ca
https://doi.org/10.1101/2023.04.14.536404
https://doi.org/10.1101/2023.04.14.536404
Autor:
Teresa Macarulla, Rodrigo Dienstmann, Josep Tabernero, Ana Vivancos, Susana Aguilar, Guillermo Villacampa, Queralt Serra-Camprubí, Sandra Peiró, Cristina Molero, Josep M. Miquel, Paulo Nuciforo, Jorge Hernando, Alexandre Sierra, Magdalena Guardiola, Daniel Alejandro Acosta, Tamara Saurí, Helena Verdaguer
Supplementary Data from ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce21c1338a49d5c61a3543c59f7a12eb
https://doi.org/10.1158/1078-0432.22482243.v1
https://doi.org/10.1158/1078-0432.22482243.v1
Autor:
Teresa Macarulla, Rodrigo Dienstmann, Josep Tabernero, Ana Vivancos, Susana Aguilar, Guillermo Villacampa, Queralt Serra-Camprubí, Sandra Peiró, Cristina Molero, Josep M. Miquel, Paulo Nuciforo, Jorge Hernando, Alexandre Sierra, Magdalena Guardiola, Daniel Alejandro Acosta, Tamara Saurí, Helena Verdaguer
Purpose:Treatment options for advanced cholangiocarcinoma are limited and prognosis is poor. Cholangiocarcinomas are highly heterogeneous at the molecular level, with divergent patterns between intrahepatic and extrahepatic forms, intrahepatic being
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::041b49d01108133d19c267fcd27c922c
https://doi.org/10.1158/1078-0432.c.6530868
https://doi.org/10.1158/1078-0432.c.6530868
Autor:
Helena Verdaguer, Tamara Saurí, Daniel Alejandro Acosta, Magdalena Guardiola, Alexandre Sierra, Jorge Hernando, Paulo Nuciforo, Josep M. Miquel, Cristina Molero, Sandra Peiró, Queralt Serra-Camprubí, Guillermo Villacampa, Susana Aguilar, Ana Vivancos, Josep Tabernero, Rodrigo Dienstmann, Teresa Macarulla
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(8)
Purpose: Treatment options for advanced cholangiocarcinoma are limited and prognosis is poor. Cholangiocarcinomas are highly heterogeneous at the molecular level, with divergent patterns between intrahepatic and extrahepatic forms, intrahepatic being
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b47e6508164d1c9321f7871369f7fd
https://pubmed.ncbi.nlm.nih.gov/35042699
https://pubmed.ncbi.nlm.nih.gov/35042699
Autor:
Carles Fabregat-Franco, Judit Matito, Agatha Martin, Helena Verdaguer, Florian Castet, Josep Maria Miquel Aymar, Gloria Castillo, Alexandre Sierra, Ana Vivancos, Teresa Macarulla
Publikováno v:
Journal of Clinical Oncology. 40:e16302-e16302
e16302 Background: Approximately 80% of pancreatic ductal adenocarcinoma (PDAC) patients present with advanced disease at diagnosis, with a 5-year survival rate of less than 5%. According to molecular profiling, mutations in KRAS have been described
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::442f93739fb8ec906b078c687ef3eb23
https://doi.org/10.1200/jco.2022.40.16_suppl.e16302
https://doi.org/10.1200/jco.2022.40.16_suppl.e16302
Autor:
Agatha Martin, E. Buxo, Javier Ros, Teresa Macarulla, J. Hernando, Helena Verdaguer, Marc Diez, Guillermo Villacampa, Francesco M. Mancuso, Ana Vivancos, Daniel Acosta, Berta Laquente, Alejandro Javier García, Cristina Molero, Iosune Baraibar, Rodrigo Dienstmann, Magda Guardiola-Fernandez, Judit Matito, Alexandre Sierra, J.M. Miquel
Publikováno v:
Web of Science
e16805 Background: Somatic DDR mut have been reported in close to 10% of PC samples. In this study we investigate their predictive value for response to platinum-based chemotherapy. Methods: Case-control study with pts deriving response to oxaliplati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8efe0ed88b893b7605b3cf862fbe32d2
https://publons.com/wos-op/publon/46781435/
https://publons.com/wos-op/publon/46781435/